Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-003560

EVP, Drug Development gave up 2,012 shares (to pay taxes)

  • EVP, Drug Development acquired 1,655 shares (other)
  • EVP, Drug Development acquired 5,814 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MANHARD KIMBERLY EVP, Drug Development 2022-10-31 Other acquisition +1,655 $3.27 $5,416 20,131 D
MANHARD KIMBERLY EVP, Drug Development 2023-01-13 Option exercise +1,250 21,381 D
MANHARD KIMBERLY EVP, Drug Development 2023-01-13 Option exercise +4,564 25,945 D
MANHARD KIMBERLY EVP, Drug Development 2023-01-13 Shares withheld for taxes −2,012 $3.17 $6,378 23,933 D
Derivatives
MANHARD KIMBERLY EVP, Drug Development 2023-01-13 Option exercise · Restricted Stock Units −1,250 8,750 D
MANHARD KIMBERLY EVP, Drug Development 2023-01-13 Option exercise · Restricted Stock Units −4,564 32,500 D
Loading xslF345X03/doc4.xml…